- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Current status of theranostics in prostate cancer ; volume:45 ; number:3 ; day:28 ; month:12 ; year:2017 ; pages:471-495 ; date:3.2018
European journal of nuclear medicine and molecular imaging ; 45, Heft 3 (28.12.2017), 471-495, 3.2018
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Virgolini, Irene
- Beteiligte Personen und Organisationen
-
Decristoforo, Clemens
Haug, Alexander Robert
Fanti, Stefano
Uprimny, Christian
SpringerLink (Online service)
- DOI
-
10.1007/s00259-017-3882-2
- URN
-
urn:nbn:de:1111-201803256180
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Virgolini, Irene
- Decristoforo, Clemens
- Haug, Alexander Robert
- Fanti, Stefano
- Uprimny, Christian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Theranostics in prostate cancer
The Current Status of Prostate Cancer
Chemodynamic nanomaterials for cancer theranostics
The Role of PSMA PET Imaging in Prostate Cancer Theranostics : A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
Multifunctional SPIONs for Theranostics in Cancer
Correction: Current status and future outlook of ultrasound treatment for prostate cancer
Current challenges in prostate cancer: an interview with Prostate Cancer UK
Persistent luminescence nanoparticles for cancer theranostics application
Norepinephrine transporter–targeted cancer theranostics — new horizons
A Multifunctional Biodegradable Nanocomposite for Cancer Theranostics
Theranostics in prostate cancer
The Current Status of Prostate Cancer
Chemodynamic nanomaterials for cancer theranostics
The Role of PSMA PET Imaging in Prostate Cancer Theranostics : A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
Multifunctional SPIONs for Theranostics in Cancer
Correction: Current status and future outlook of ultrasound treatment for prostate cancer
Current challenges in prostate cancer: an interview with Prostate Cancer UK
Persistent luminescence nanoparticles for cancer theranostics application
Norepinephrine transporter–targeted cancer theranostics — new horizons
A Multifunctional Biodegradable Nanocomposite for Cancer Theranostics
Theranostics in prostate cancer
The Current Status of Prostate Cancer
Chemodynamic nanomaterials for cancer theranostics
The Role of PSMA PET Imaging in Prostate Cancer Theranostics : A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
Multifunctional SPIONs for Theranostics in Cancer
Correction: Current status and future outlook of ultrasound treatment for prostate cancer
Current challenges in prostate cancer: an interview with Prostate Cancer UK
Persistent luminescence nanoparticles for cancer theranostics application
Norepinephrine transporter–targeted cancer theranostics — new horizons